Warum Bitcoin als Wertspeicher in keinem diversifizierten Portfolio fehlen sollte. Jetzt lesen -w-
14.03.2022 10:15:20

DGAP-AFR: STADA Arzneimittel AG: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]

DGAP Preliminary announcement financial reports: STADA Arzneimittel AG / Preliminary announcement on the disclosure of financial statements
STADA Arzneimittel AG: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]

14.03.2022 / 10:15
Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act] transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


STADA Arzneimittel AG hereby announces that the following financial reports shall be disclosed:

Report Type: Annual financial report

Language: German
Date of disclosure: March 22, 2022
Address: https://www.stada.com/de/gj2021-jahresabschluss.pdf

Language: English
Date of disclosure: March 22, 2022
Address: https://www.stada.com/fy2021-financial-statements.pdf


14.03.2022 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Language: English
Company: STADA Arzneimittel AG
Stadastraße 2-18
61118 Bad Vilbel
Germany
Internet: www.stada.de

 
End of News DGAP News Service

1301509  14.03.2022 

fncls.ssp?fn=show_t_gif&application_id=1301509&application_name=news&site_id=smarthouse

Analysen zu STADAmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!